RFK Jr. Just Declared War on Big Pharma—Now What?

His CDC overhaul could crush vaccine stocks. Should you buy, sell, or run?

In partnership with

RFK Jr.’s CDC Shake-Up: Should You Buy or Sell Vaccine Stocks?

RFK Jr. just took a flamethrower to the CDC—ousting long-time leadership and calling for criminal probes into vaccine-related policies.

This isn't just political theater—it could send shockwaves through the biotech and pharma sectors. So what does it mean for vaccine stocks—and for your portfolio?

1440: Your Weekly Business Cheat Sheet

Expand your business and finance knowledge with 1440. Get clear, conversational breakdowns of the key concepts in business and finance—no paywalls, no spin. Every Thursday, 1440 delivers deep dives, interactive charts, and rapid market rundowns trusted by 100k+ professionals.

WWDC 2025: Liquid Glass UI vs. AI Stagnation—What It Means for Apple Investors

Apple took the stage at its Worldwide Developers Conference2025. Investors tuned in, hoping for a bold leap forward—maybe a revamped Siri or a new gadget to justify Apple’s $3.2 trillion valuation. Instead, they got a slick new look called Liquid Glass and a handful of software tweaks, but no game-changing AI breakthroughs or hardware reveals. The result? A 1.21% dip in Apple’s stock price and a flurry of chatter on X questioning whether the company’s still got its edge.

Trump on Elon Musk, Tesla, StarLink & Drug Rumors: “I Wish Him Well”
Apple’s WWDC 2025 Was… Underwhelming? “The Bar Was on the Floor”

Know what you own, and know why you own it.

-Peter Lynch

Styled Text

You are receiving this email because you opted in to receive updates from Global Market News. This newsletter may contain sponsored content or advertisements. Information provided is for informational purposes only and should not be considered financial or investment advice. Always consult a financial advisor before making investment decisions.